Latest Blog Posts Tagged "Research News"
March 29, 2016
An FDA advisory committee voted 12-2 in favor of approval of Nuplazid, a drug for Parkinson's disease psychosis. The agency will make its decision by May 1, 2016.
January 29, 2016
Today a group of researchers led and funded by MJFF published an important finding that opens the door to more research around the Parkinson's process.
January 18, 2016
In our latest podcast, Christopher Bishop, PhD, discusses what may cause involuntary movements called dyskinesia with long-term Parkinson's disease and medication use.
January 07, 2016
MJFF, Cynapsus and Intel announce a pilot incorporating wearable devices and "big data" approaches into a trial of a drug to help patients return to "on" from "off" episodes.
December 28, 2015
Adamas has announced positive Phase III results for its treatment for dyskinesia, involuntary movements that are a side effect of levodopa use. Such a therapy could impact how we treat motor symptoms.
December 11, 2015
We talk to the author of a new study that links milk consumption to PD in a male Hawaiian population most likely through dairy contamination with pesticides.
December 04, 2015
Author John Grisham publishes a new book about focused ultrasound treatment.
November 23, 2015
The new MDS Clinical Diagnostic Criteria for Parkinson's Disease reflects our updated understanding of, for example, genetics and non-motor symptoms.
October 20, 2015
A research study reports improved symptoms and impact on Parkinson's disease biology with a cancer drug. See what an MJFF Scientific Advisory Board member has to say about these results.
October 02, 2015
Test your knowledge of promising treatments.